Skip to main
KLRS
KLRS logo

Allovir Inc (KLRS)

We couldn’t load this chart.

Some asset charts might currently not be supported. To try again, please refresh this page.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Allovir Inc (KLRS) Stock

About Allovir Inc (KLRS)

Kalaris Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on developing and commercializing innovative therapeutics for retinal diseases. It is focusing on developing TH103, a novel anti-VEGF agent targeted at treating neovascular and exudative retinal diseases. The company is headquartered in Palo Alto, CA.
Market cap$51.62M
Friday's volume41.3K
Revenue (TTM)
Avg. daily volume51.71K
EBITDA (TTM)-$42.78M
Open$2.81
Price / earnings ratio-0.34x
Friday's range$2.66 - $2.96
Debt / equity
52 week range$2.28 - $24.15
5 year debt / equity7.19x
Beta (LTM)0.9x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio14.31x
Ex-dividend date
Next earningsAug 15, 2025
Dividend payable date

Frequently Asked Questions (FAQ)

As of Jul 26, 2025, the market cap for KLRS stock is $51.62M

The current P/E ratio for KLRS stock is -0.34

The 52-week high for KLRS stock is $24.15. The current KLRS stock price $undefined is 100.00% below its 52-week high

The 52-week low for KLRS stock is $2.28. The current KLRS stock price $undefined has increased 100.00% from its 52-week low

No, the KLRS stock does not pay dividends to its shareholders

How to buy KLRS stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in KLRS stock

    Navigate to the Explore page. Then, type KLRS into the search bar. When you see KLRS stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased KLRS stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Allovir Inc Stock Earnings

The value each KLRS share was expected to gain vs. the value that each KLRS share actually gained.

Allovir Inc (KLRS) reported earnings per share (EPS) of $0, estimates of $0 by . In the same quarter last year, Allovir Inc's earnings per share (EPS) was $0. Allovir Inc is expected to release next earnings on 08/15/2025, with an earnings per share (EPS) estimate of -$0.51.

Buy Allovir Inc (KLRS) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.